Pain Modulation in RA - Influence of Adalimumab. A Randomized, Placebo-controlled Study Using Functional Magnetic Resonance Imaging (PARADE).
Phase of Trial: Phase III
Latest Information Update: 05 Feb 2018
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms PARADE
- 18 May 2017 Status changed from recruiting to completed.
- 04 Feb 2016 Planned End Date changed from 1 Mar 2013 to 1 Dec 2016 as reported by ClinicalTrials.gov
- 29 Nov 2010 Actual initiation date (Oct 2010) added as reported by ClinicalTrials.gov.